It is a pharma private limited company based in Ghaziabad, Uttar Pradesh, India, established in 2022.
2022 | Ghaziabad, Uttar Pradesh, India | ActiveRimedile Pharmaceutical Private Limited, a active private limited company, was established on 23 June 2022 in Ghaziabad, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51909UP2022PTC166290. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Atul Gupta (Director), Rikesh Kumar (Director). Past directors included Satendra Singh. Its latest AGM occurred on 27 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-15 Indirapuri Loni, Ghaziabad, Uttar Pradesh, 201102.
U51909UP2022PTC166290
166290
23 June 2022
₹0.10 M
₹0.10 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Rimedile Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Atul Gupta | Director | 23 Jun 2022 | Current |
| Rikesh Kumar | Director | 23 Jun 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Nov 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Rimedile Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Rimedile Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Rimedile Pharmaceutical has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rimedile Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rimedile Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Rimedile Pharmaceutical Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records. was documented.
The activity Rimedile Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.
Progress on Atul Gupta was appointed as a Director was appointed as a Director on 23 Jun 2022 & has been associated with this company since 3 years 6 months . was documented.
Rikesh Kumar was appointed as a Director was appointed as a Director on 23 Jun 2022 & has been associated with this company since 3 years 6 months . was recorded as a recent event.
The activity Rimedile Pharmaceutical Private Limited was registered on 23 Jun 2022 with Roc Kanpur & aged 3 years 6 months as per MCA records. was completed.
The CIN of Rimedile Pharmaceutical Private Limited is U51909UP2022PTC166290.
Rimedile Pharmaceutical Private Limited is headquartered at A-15 Indirapuri Loni, Ghaziabad, Uttar Pradesh, 201102.
Rimedile Pharmaceutical Private Limited was incorporated on 23 June 2022.
The current directors of Rimedile Pharmaceutical Private Limited are
The primary industry of Rimedile Pharmaceutical Private Limited is Pharma.
Rimedile Pharmaceutical Private Limited is unlisted.
The authorized capital of Rimedile Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX